trial_id	eligibility_criteria
ACTRN12613000198729	catype:Ewing sarcoma
ACTRN12613000198729	catype:Osteosarcoma
ACTRN12613000198729	catype:Sarcoma
ACTRN12613000198729	catype:Small-cell lung cancer
ACTRN12613000198729	catype:Triple-negative breast cancer
ACTRN12613000198729	catype:melanoma
ACTRN12617000741381	TRANSPLANT_RELATED_CANCERS
ACTRN12617001190392	NOT KRAS:oncogenic_mutation; NOT NRAS:oncogenic_mutation
ACTRN12617001325392	ERBB2:amplification
ACTRN12617001573347	NOT catype:Glioblastoma
ACTRN12619001265167	NOT catype:Non-small cell lung cancer; (ERBB2:amplification OR ERBB2:overexpression OR ERBB2:oncogenic_mutation); NOT catype:Breast cancer; NOT catype:Gastric adenocarcinoma; NOT catype:Gastric cancer; NOT catype:Gastroesophageal adenocarcinoma; *NOT_RECRUITING
ACTRN12619001265167	catype:Non-small cell lung cancer; (ERBB2:amplification OR ERBB2:overexpression OR ERBB2:oncogenic_mutation); *NOT_RECRUITING
ACTRN12618000233224	NOT_RECRUITING; NOT BRAF:V600E; NOT KRAS:oncogenic_mutation; NOT NRAS:oncogenic_mutation
ACTRN12618000281291	*NOT catype:Basal Cell Carcinoma; *NOT prior_therapy:Vismodegib
ACTRN12618000357257	catype:Angiosarcoma; NOT_RECRUITING
ACTRN12619000844145	ALK:fusion
ACTRN12619001117101	PIK3CA:oncogenic_mutation; NOT ERBB2:amplification; NOT ERBB2:over_expression
ACTRN12619001185156	*(CCNE1:amplification OR CCNE1:overexpression); *catype:High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum; catype:Ovarian cancer
ACTRN12619001527156	(catype:Head and Neck Squamous Cell Carcinoma OR catype:Triple-Negative Breast Cancer OR catype:Adenoid Cystic Carcinoma)
ACTRN12620000568910	(CDK4:oncogenic_mutation OR CDK4:amplification OR CCND1:amplification OR CCND2:amplification OR CCND3:amplification OR CCND1:oncogenic_mutation OR CCND2:oncogenic_mutation OR CCND3:oncogenic_mutation); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910	(CDKN2A:loss-of-function_mutation OR CDKN2A:deletion); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910p	(CDK4:oncogenic_mutation OR CDK4:amplification OR CCND1:amplification OR CCND2:amplification OR CCND3:amplification OR CCND1:oncogenic_mutation OR CCND2:oncogenic_mutation OR CCND3:oncogenic_mutation); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910p	(CDKN2A:loss-of-function_mutation OR CDKN2A:deletion); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000861954	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_variant); (catype:Solid tumour OR catype:Non-small cell lung cancer); *NOT catype:Colorectal cancer
ACTRN12620000861954p	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_variant); (catype:Solid tumour OR catype:Non-small cell lung cancer); *NOT catype:Colorectal cancer
ACTRN12620000918921	catype:Solid tumour; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; tumour_mutational_burden:high
ACTRN12620000984998	*NOT catype:Chondrosarcoma; NOT_RECRUITING
ACTRN12620000984998	NOT catype:Osteosarcoma; NOT_RECRUITING
ACTRN12620001146987	MYC:alteration
ACTRN12621000284864	(ROS1:fusion OR NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion)
ACTRN12621000312842	(ALK:fusion OR ALK:oncogenic_mutation)
ACTRN12621000507886	catype:lymphoma
ACTRN12621000639820	(catype:Endometrial cancer OR catype:Ovarian cancer OR catype:Fallopian tube carcinoma OR catype:Peritneal serous carcinoma OR catype:Endometrial stromal sarcoma OR catype:Uterine leiomyosarcoma OR catype:Granulosa cell tumour)
ACTRN12621000811808	(MET:exon_14_skipping_mutation OR MET:exon_14_deletion)
ACTRN12622000973718	catype:Non-small cell lung cancer; KRAS:G12C
ACTRN12621001436864	BRAF:V600E; NOT KRAS:oncogenic_mutation
ACTRN12621001436864	KRAS:oncogenic_mutation
ACTRN12621001690842	NOT catype:Non-small cell lung cancer; NOT catype:Colorectal cancer
ACTRN12620000767909	NOT catype:Breast cancer; NOT catype:Gastric adenocarcinoma; NOT catype:Gastric cancer; NOT catype:Gastroesophageal adenocarcinoma
NCT02408861	HIV_POSITIVE
NCT02568267	(NTRK1:oncogenic_mutation OR NTRK2:oncogenic_mutation OR NTRK3:oncogenic_mutation OR ROS1:oncogenic_mutation OR ALK:oncogenic_mutation)
NCT02576431	(NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion OR ROS1:fusion)
NCT02609776	MET:exon_14_skipping_mutation; *(prior_therapy:Carboplatin OR prior_therapy:Cisplatin)
NCT02609776	MET:oncogenic_mutation
NCT02628067	catype:Anal Cancer
NCT02628067	catype:Biliary Tract Cancer
NCT02628067	catype:Cervical Cancer
NCT02628067	catype:Colorectal cancer; NOT microsatellite_instability:high; NOT mismatch_repair:deficient
NCT02628067	catype:Endometrial Carcinoma
NCT02628067	catype:Lung Neuroendocrine Tumor
NCT02628067	catype:Mesothelioma
NCT02628067	catype:Pancreatic Neuroendocrine Tumor
NCT02628067	catype:Salivary Gland Carcinoma
NCT02628067	catype:Small bowel Neuroendocrine Tumor
NCT02628067	catype:Small-Cell Lung Carcinoma
NCT02628067	catype:Thyroid Carcinoma
NCT02628067	catype:Vulvar Cancer
NCT02628067	microsatellite_instability:high
NCT02960022	*prior_therapy:Enzalutamide
NCT03093116	(NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion OR ROS1:fusion)
NCT03093116	ALK:fusion
NCT03157128	RET:fusion
NCT03157128	RET:oncogenic_mutation; NOT RET:amplification
NCT03175224	(MET:oncogenic_mutation OR MET:alteration)
NCT03178552	*NOT prior_therapy:systemic_therapy
NCT03212404	catype:Classical Hodgkin Lymphoma
NCT03212404	catype:Colorectal Cancer; (microsatellite_instability:high OR mismatch_repair:deficient)
NCT03212404	catype:Colorectal cancer; microsatellite_instability:high
NCT03212404	catype:Colorectal cancer; mismatch_repair:deficient
NCT03212404	catype:Cutaneous Squamous Cell Carcinoma
NCT03212404	catype:Cutaneous squamous cell carcinoma
NCT03212404	catype:Endometrial Cancer
NCT03212404	catype:Head and Neck Cancer
NCT03212404	catype:Head and neck squamous cell carcinoma
NCT03212404	catype:Hodgkin's lymphoma
NCT03212404	catype:Melanoma
NCT03212404	catype:Melanoma
NCT03212404	catype:Merkel Cell Carcinoma
NCT03212404	catype:Merkel cell carcinoma
NCT03212404	catype:Mesothelioma
NCT03212404	catype:Mesothelioma
NCT03212404	catype:Non Hodgkin Lymphoma
NCT03212404	catype:Non-Hodgkin's lymphoma
NCT03212404	catype:Non-Small-Cell Lung Cancer
NCT03212404	catype:Non-small cell lung cancer
NCT03212404	catype:Renal Cell Carcinoma
NCT03212404	catype:Renal cell carcinoma
NCT03212404	catype:Small-Cell Lung Cancer
NCT03212404	catype:Small-cell lung cancer
NCT03212404	catype:Urothelial Carcinoma
NCT03212404	catype:Urothelial carcinoma
NCT03255070	(ERBB2:oncogenic_mutation OR ERBB2:amplification OR ERBB2:overexpression)
NCT03278717	NOT catype:Ovarian clear cell carcinoma; NOT catype:Ovarian carcinosarcoma; NOT catype:Ovarian mucinous carcinoma
NCT03319940	catype:Small-cell lung carcinoma
NCT03363776	catype:Breast
NCT03363776	catype:Colorectal
NCT03363776	catype:Ovarian
NCT03363776	catype:Pancreatic
NCT03363776	catype:Prostate
NCT03363776	catype:Urothelial carcinoma
NCT03363867	NOT catype:Ovarian Clear cell Carcinoma; NOT catype:Ovarian Mucinous Carcinoma; NOT catype:Ovarian Carcinosarcoma
NCT03369223	NOT catype:central nervous system cancer
NCT03390504	(FGFR1:alteration OR FGFR2:alteration OR FGFR3:alteration)
NCT03424005	NOT ERBB2:amplification
NCT03486873	EXTENSION_STUDY
NCT03497767	EGFR:oncogenic_mutation
NCT03539536	MET:alteration; catype:Non-small cell lung cancer
NCT03551626	BRAF:V600_missense_variant
NCT03600883	KRAS:G12C
NCT03674567	catype:Cervical cancer
NCT03674567	catype:Gastric cancer
NCT03674567	catype:Head and neck squamous cell carcinoma
NCT03674567	catype:Hodgkin lymphoma
NCT03674567	catype:Nasopharyngeal carcinoma
NCT03674567	catype:Non-small cell lung cancer
NCT03674567	catype:Oesophageal carcinoma
NCT03674567	catype:Triple-negative breast cancer
NCT03674567	catype:Urothelial carcinoma
NCT03739710	catype:NSCLC
NCT03742895	NOT catype:Ovarian cancer; NOT catype:Breast cancer; (BRCA1:oncogenic_mutation OR BRCA2:oncogenic_mutation)
NCT03742895	catype:Breast cancer; NOT BRCA1:oncogenic_mutation; NOT BRCA2:oncogenic_mutation
NCT03742895	catype:Ovarian cancer; NOT BRCA1:oncogenic_mutation; NOT BRCA2:oncogenic_mutation
NCT03748134	NOT catype:Gastroesophageal junction carcinoma; NOT catype:Gastroesophageal junction adenocarcinoma
NCT03773302	FGFR2:fusion
NCT03773302	NOT catype:Cholangiocarcinoma
NCT03773302	catype:Cholangiocarcinoma
NCT03798626	(catype:Colorectal cancer OR catype:Gastric cancer OR catype:Gastroesophageal cancer OR catype:Renal cell carcinoma)
NCT03821935	catype:Head and neck squamous cell carcinoma
NCT03821935	catype:Hepatocellular carcinoma
NCT03821935	catype:Pancreatic adenocarcinoma
NCT03821935	catype:Triple-negative breast cancer
NCT03821935	catype:Urothelial cancer
NCT03878719	BRAF:V600_missense_variant
NCT03905148	*NOT catype:CNS cancer
NCT03906331	RET:fusion
NCT03906331	RET:oncogenic_mutation; NOT RET:amplification
NCT03947385	(GNAQ:oncogenic_mutation OR GNA11:oncogenic_mutation OR PRKC:fusion)
NCT03974022	(ERBB2:oncogenic_mutation OR EGFR:oncogenic_mutation)
NCT03975647	(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:protein_expression)
NCT03994393	catype:Non-small cell lung cancer; (EGFR:L858R OR EGFR:exon_19_deletion)
NCT04000529	(catype:Non-small cell lung cancer OR catype:Head and neck squamous cell carcinoma OR catype:Oesophageal squamous cell carcinoma OR catype:Gastrointestinal stromal tumour OR catype:Colorectal cancer)
NCT04008030	(MSI:H OR MMR:deficient)
NCT04064060	NOT catype:solid tumours
NCT04083976	NOT catype:Urothelial carcinoma; NOT catype:Bladder cancer; (FGFR1:fusion OR FGFR2:fusion OR FGFR3:fusion)
NCT04083976	NOT catype:Urothelial carcinoma; NOT catype:Bladder cancer; (FGFR1:oncogenic_mutation OR FGFR2:oncogenic_mutation OR FGFR3:oncogenic_mutation OR FGFR4:oncogenic_mutation); NOT FGFR1:fusion; NOT FGFR2:fusion; NOT FGFR3:fusion; (FGFR1:missense_variant OR FGFR1:indel OR FGFR1:fusion OR FGFR2:indel OR FGFR2:missense_variant OR FGFR2:fusion OR FGFR3:missense_variant OR FGFR3:indel OR FGFR3:fusion OR FGFR4:missense_variant OR FGFR4:indel OR FGFR4:fusion); NOT FGFR1:resistance_mutations,pan-FGFR_inhibitor; *(FGFR1:S125L OR FGFR1:P150S OR FGFR1:R189C OR FGFR1:K656E OR FGFR2:W72C OR FGFR2:A97T OR FGFR2:D101Y OR FGFR2:R203H OR FGFR2:R210Q OR FGFR2:E219K OR FGFR2:R251Q OR FGFR2:S252L OR FGFR2:S252P OR FGFR2:S252T OR FGFR2:S252A OR FGFR2:P253L OR FGFR2:S267P OR FGFR2:F276C OR FGFR2:W290R OR FGFR2:W290C OR FGFR2:D304N OR FGFR2:Y308C OR FGFR2:A315T OR FGFR2:G338R OR FGFR2:Y340C OR FGFR2:S351C OR FGFR2:S354C OR FGFR2:T370R OR FGFR2:S372C OR FGFR2:Y375C OR FGFR2:C382F OR FGFR2:C382R OR FGFR2:A389T OR FGFR2:C390Y OR FGFR2:C390S OR FGFR2:V395D OR FGFR2:K526E OR FGFR2:M535I OR FGFR2:M537I OR FGFR2:I547V OR FGFR2:L550F OR FGFR2:E565G OR FGFR2:E565Q OR FGFR2:E565A OR FGFR2:L617F OR FGFR2:K641R OR FGFR2:K659M OR FGFR2:K659N OR FGFR2:W678G OR FGFR2:E731K OR FGFR2:L770* OR FGFR2:L770V OR FGFR2:E777* OR FGFR2:E777K OR FGFR3:S84L OR FGFR3:R248J OR FGFR3:R248C OR FGFR3:S249Y OR FGFR3:S249F OR FGFR3:S249C OR FGFR3:P250R OR FGFR3:Y278C OR FGFR3:L324V OR FGFR3:G370S OR FGFR3:G370C OR FGFR3:S371G OR FGFR3:S371R OR FGFR3:S371C OR FGFR3:Y373N OR FGFR3:Y373H OR FGFR3:Y373C OR FGFR3:G380E OR FGFR3:F384L OR FGFR3:A391V OR FGFR3:R399C OR FGFR3:S433C OR FGFR3:A500T OR FGFR3:M528I OR FGFR3:P572A OR FGFR3:P572L OR FGFR3:E627D OR FGFR3:D641N OR FGFR3:K650T OR FGFR3:K650N OR FGFR3:K650Q OR FGFR3:R669Q OR FGFR3:R750C OR FGFR4:Y367C)
NCT04123366	(BRCA1:oncogenic_mutation OR BRCA2:oncogenic_mutation OR ATM:oncogenic_mutation OR BARD1:oncogenic_mutation OR BRIP1:oncogenic_mutation OR CDK12:oncogenic_mutation OR CHEK1:oncogenic_mutation OR CHEK2:oncogenic_mutation OR FANCL:oncogenic_mutation OR PALB2:oncogenic_mutation OR PPP2R2A:oncogenic_mutation OR RAD51B:oncogenic_mutation OR RAD51C:oncogenic_mutation OR RAD51D:oncogenic_mutation OR RAD54L:oncogenic_mutation OR loss_of_heterozygosity_score:high OR homologous_recombination_score:high); NOT catype:Breast cancer; NOT catype:Ovarian cancer
NCT04129502	EGFR:exon_20_insertion
NCT04161885	catype:Acute Myeloid Leukemia
NCT04164199	access:by_invitation_only
NCT04170283	NOT catype:solid tumours
NCT04185883	KRAS:G12C
NCT04188548	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04191499	catype:Breast cancer; NOT ERBB2:amplification; PIK3CA:alteration
NCT04194944	RET:fusion; *NOT prior_therapy:systemic_therapy
NCT04211337	(RET:oncogenic_mutation OR RET:fusion)
NCT04222972	catype:Non-small cell lung cancer; RET:fusion
NCT04223856	*NOT prior_therapy:systemic_therapy
NCT04249843	(BRAF:alteration OR KRAS:alteration OR NRAS:alteration); NOT catype:Colorectal cancer; NOT catype:Pancreatic cancer
NCT04249843	BRAF:alteration; BRAF:V600E; catype:Melanoma
NCT04249843	BRAF:alteration; BRAF:V600E; catype:Non-small cell lung carcinoma
NCT04249843	BRAF:alteration; NOT BRAF:V600E
NCT04251117	catype:Hepatocellular carcinoma
NCT04251533	(PIK3CA:oncogenic_mutation OR PTEN:oncogenic_mutation OR PTEN:loss_of_protein_expression); NOT ERBB2:amplification; NOT ERBB2:over_expression
NCT04262856	*NOT prior_therapy:systemic_therapy
NCT04269200	NOT catype:Leiomyosarcoma
NCT04277637	NOT catype:solid tumours
NCT04282018	catype:Cervical cancer
NCT04282018	catype:Endometrial carcinoma
NCT04282018	catype:Gastric cancer
NCT04282018	catype:Gastroesophageal junction carcinoma
NCT04282018	catype:Haematologic cancer
NCT04282018	catype:Head and neck squamous cell carcinoma
NCT04282018	catype:Hepatocellular carcinoma
NCT04282018	catype:Melanoma
NCT04282018	catype:Nasopharyngeal carcinoma
NCT04282018	catype:Non-small cell lung cancer
NCT04282018	catype:Oesophageal cancer
NCT04282018	catype:Ovarian cancer
NCT04282018	catype:Renal cell carcinoma
NCT04282018	catype:Small cell lung cancer
NCT04282018	catype:Triple-negative breast cancer
NCT04282018	catype:Urothelial carcinoma
NCT04282018	microsatellite_instability:high
NCT04282018	mismatch_repair:deficient
NCT04294160	BRAF:V600E
NCT04294810	NOT EGFR:oncogenic_mutation; NOT ALK:fusion
NCT04300244	catype:Mesothelioma
NCT04305496	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04311710	catype:Hepatocellular carcinoma
NCT04311710	catype:Melanoma
NCT04311710	catype:Non-small cell lung cancer
NCT04311710	catype:Renal cell carcinoma
NCT04311710	catype:Urothelial carcinoma
NCT04383210	NRG1:fusion
NCT04417621	catype:Melanoma; (BRAF:V600_misssense_mutation OR NRAS:oncogenic_mutation)
NCT04418661	(KRAS:oncogenic_mutation OR KRAS:amplification OR BRAF:class_3_mutation OR NF1:loss-of-function_mutation OR NF1:oncogenic_mutation OR NF1:deletion OR NF1:oncogenic_mutation OR KRAS:G12C); NOT catype:Central nervous system cancer
NCT04427072	MET:exon_14_skipping_mutation
NCT04434482	NOT catype:central nervous system cancer
NCT04447118	ERBB2:exon_20_mutation
NCT04449874	KRAS:G12C; catype:Colorectal cancer
NCT04449874	KRAS:G12C; catype:Non-small cell lung cancer
NCT04449874	KRAS:G12C; catype:Solid tumour
NCT04450732	(ERBB2:oncogenic_mutation OR ERBB2:amplification OR ERBB2:overexpression)
NCT04505826	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04516447	(catype:Ovarian cancer OR catype:Fallopian tube carcinoma OR catype:Peritoneal serous carcinoma); *catype:High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
NCT04521686	IDH1:oncogenic_mutation
NCT04538664	EGFR:exon_20_insertion; *NOT prior_therapy:EGFR_inhibitor,exon_20_selective
NCT04538742	(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:protein_expression)
NCT04546009	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04565275	(FGFR1:alteration OR FGFR2:alteration OR FGFR3:alteration); *NOT prior_therapy:pan-FGFR_inhibitor
NCT04585035	KRAS:G12C
NCT04585815	BRAF:V600E
NCT04589845	(sensitive_to:GDC-0077 OR sensitive_to_drug_class:PI3K_inhibitor); *(PIK3CA:E542_missense_variant OR PIK3CA:E545_missense_variant OR PIK3CA:H1047_missense_variant); *(PIK3CA:E81K OR PIK3CA:E88Q OR PIK3CA:E88P OR PIK3CA:R93Q OR PIK3CA:R93W OR PIK3CA:P104L OR PIK3CA:G106_missense_variant  OR PIK3CA:R108_missense_variant OR PIK3CA:K111_missense_variant  OR PIK3CA:G118_missense_variant OR PIK3CA:N345_missense_variant OR PIK3CA:R357_missense_variant OR PIK3CA:C378_missense_variant OR PIK3CA:C420_missense_variant OR PIK3CA:E453_missense_variant OR PIK3CA:E542_missense_variant OR PIK3CA:E545_missense_variant OR PIK3CA:Q546_missense_variant OR PIK3CA:M1004_missense_variant OR PIK3CA:M1043_missense_variant OR PIK3CA:H1047_missense_variant OR PIK3CA:H1048_missense_variant OR PIK3CA:G1049_missense_variant)
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:G222C OR ERBB2:R226S OR ERBB2:E265K OR ERBB2:D277H OR ERBB2:G292R OR ERBB2:G309A OR ERBB2:G309E OR ERBB2:S310F OR ERBB2:S310Y OR ERBB2:C311R OR ERBB2:C311S OR ERBB2:E321G OR ERBB2:C334S)
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:P551L OR ERBB2:R552S OR ERBB2:S418T OR ERBB2:A440T)
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:S653C OR ERBB2:V659E OR ERBB2:G660D OR ERBB2:R678Q)
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:T733I OR ERBB2:L755P OR ERBB2:L755S OR ERBB2:I767M OR ERBB2:L768S OR ERBB2:D769H OR ERBB2:D769N OR ERBB2:D769Y OR ERBB2:A775_Y776insYVMA OR ERBB2:A775_Y776ins OR ERBB2:L775P OR ERBB2:L775S OR ERBB2:L775_T759del OR ERBB2:G776delinsVC OR ERBB2:G776delinsVV OR ERBB2:G776delinsLC OR ERBB2:V777L OR ERBB2:G778_P780dup OR ERBB2:V779A OR ERBB2:V779L OR ERBB2:T798M OR ERBB2:L841V OR ERBB2:V842I OR ERBB2:N875S OR ERBB2:T862A OR ERBB2:L869A OR ERBB2:L869R OR ERBB2:H878Y OR ERBB2:R896C)
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); (AKT1:E17K OR AKT1:L52R OR AKT1:Q79K); *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); (AKT3:E17K OR AKT3:L51R OR AKT3:Q78K); *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); AKT2:E17K; *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	COHORT_CLOSED; sensitive_to_drug_class:MDM2_inhibitor; MDM2:amplification; NOT TP53:oncogenic_mutation; catype:Liquid cancer
NCT04589845	sensitive_to:Alectinib; ALK:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ALK_inhibitor; *NOT ALK:I1171N; *NOT ALK:I1171S; *NOT ALK:G1202R
NCT04589845	sensitive_to:Entrectinib; (NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion); *NOT prior_therapy:NTRK_inhibitor
NCT04589845	sensitive_to:Entrectinib; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	sensitive_to_drug_class:ALK_inhibitor,second_generation; ALK:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ALK_inhibitor
NCT04589845	sensitive_to_drug_class:NTRK_inhibitor; (NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion); *NOT prior_therapy:NTRK_inhibitor
NCT04589845	(sensitive_to_drug_class:RAF_dimer_inhibitor OR sensitive_to:Belvarafenib); (BRAF:fusion OR BRAF:class_2_mutation OR BRAF:class_3_mutation)
NCT04589845	sensitive_to_drug_class:ROS1_inhibitor; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	sensitive_to_drug_class:ROS1_inhibitor; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	tumour_mutational_burden:high; *NOT prior_therapy:immune_checkpoint_blockade
NCT04606446	(catype:Breast cancer OR catype:Prostate cancer OR catype:Non-small cell lung cancer)
NCT04607421	BRAF:V600E; catype:Colorectal cancer
NCT04619004	catype:Non-small-cell lung cancer; (EGFR:L858R OR EGFR:exon_19_deletion)
NCT04624204	catype:Small-cell lung carcinoma
NCT04655976	NOT ALK:fusion; NOT EGFR:oncogenic_mutation; NOT NTRK1:fusion; NOT NTRK2:fusion; NOT NTRK3:fusion; NOT ROS1:fusion; NOT BRAF:V600E
NCT04623775	catype:Non-small cell lung cancer; NOT ALK:fusion; NOT EGFR:oncogenic_mutation; NOT NTRK1:fusion; NOT NTRK2:fusion; NOT NTRK3:fusion; NOT ROS1:fusion; NOT BRAF:V600E
NCT04665206	(NF2:oncogenic_mutation OR NF2:alteration)
NCT04699188	KRAS:G12C
NCT04720768	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_mutation)
NCT04721015	catype:Non-small cell lung cancer
NCT04746924	NOT ALK:fusion; NOT EGFR:oncogenic_mutation
NCT04760288	RET:alteration
NCT04793958	KRAS:G12C; catype:Colorectal adenocarcinoma
NCT04849273	ALK:fusion
NCT04857372	catype:Mesothelioma
NCT04857372	catype:Solid tumour; (YAP1:fision OR NF2:oncogenic_mutation)
NCT04895358	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04907851	(catype:Biliary tract cancer OR catype:Gallbladder cancer OR catype:Cholangiocarcinoma OR catype:Ampullary cancer)
NCT04907851	RNF43:oncogenic_mutation; *RNF43:loss-of-function_mutation; *(RNF43:A46V OR RNF43:I48T OR RNF43:G67C OR RNF43:G67D OR RNF43:F69C OR RNF43:A73F OR RNF43:A73V OR RNF43:G80E OR RNF43:G80R OR RNF43:L82S OR RNF43:K108E OR RNF43:R127P OR RNF43:G133E OR RNF43:A136T OR RNF43:P154L OR RNF43:V162M OR RNF43:G166V OR RNF43:A169T OR RNF43:I186T OR RNF43:C275F OR RNF43:R286Q OR RNF43:R286W OR RNF43:C290F OR RNF43:H292R OR RNF43:E293K OR RNF43:H295R OR RNF43:R296H OR RNF43:C298Y OR RNF43:D300G OR RNF43:D300Y OR RNF43:P301S OR RNF43:R307W OR RNF43:C309F OR RNF43:P310A OR RNF43:C312W OR RNF43:Q22* OR RNF43:G29* OR RNF43:S41* OR RNF43:A46V OR RNF43:F69Lfs* OR RNF43:L82S OR RNF43:R113* OR RNF43:R117fs* OR RNF43:R132* OR RNF43:R145* OR RNF43:R152* OR RNF43:Q153* OR RNF43:P154L OR RNF43:W159* OR RNF43:V162M OR RNF43:A169T OR RNF43:I186T OR RNF43:W200* OR RNF43:W200Sfs* OR RNF43:S216* OR RNF43:R225Afs* OR RNF43:W259* OR RNF43:L311Sfs* OR RNF43:R330* OR RNF43:R337* OR RNF43:R371*)
NCT04969887	(catype:Biliary tract cancer OR catype:Gallbladder cancer OR catype:Cholangiocarcinoma); *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	(catype:Lung neuroendocrine tumour OR catype:Neuroendocrine carcinoma); NOT catype:Small-cell lung carcinoma; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	catype:Gynaecological cancer; (catype:Ovarian Clear Cell Carcinoma OR catype:Uterine Clear Cell Carcinoma OR catype:Uterine carcinosarcoma OR catype:Ovarian carcinosarcoma OR catype:Uterine leiomyosarcoma OR catype:Carcinosarcoma OR catype:Uterine carcinosarcoma OR catype:Vaginal cancer OR catype:Vulvar cancer); *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	microsatellite_instability:high; NOT catype:Colorectal cancer; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	mismatch_repair:deficient; NOT catype:Colorectal cancer; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04956640	KRAS:G12C; *NOT prior_therapy:KRAS_G12C_inhibitor
NCT04913285	(BRAF:oncogenic_mutation OR NRAS:oncogenic_mutation)
NCT04975308	catype:Breast cancer
NCT05067283	KRAS:G12C
NCT05084859	(catype:Non-small cell lung cancer OR catype:Prostate cancer OR catype:Colorectal cancer)
NCT05150236	catype:Prostate cancer
NCT05198934	KRAS:G12C; catype:Colorectal cancer
NCT05288166	catype:Prostate cancer
NCT05059522	prior_therapy:Avelumab
NCT03611868	(catype:Melanoma OR catype:Malignant peripheral nerve sheath tumor)
NCT05217446	BRAF:V600E; (microsatellite_instability:high OR mismatch_repair:deficient)
NCT05054725	KRAS:G12C
NCT04472429	catype:Anal cancer
NCT03900442	(catype:Multiple myeloma OR catype:Peripheral T-cell lymphoma OR catype:Colorectal cancer OR catype:Pancreatic adenocarcinoma)
NCT03900442	catype:Gastric cancer; *catype:Diffuse gastric cancer
NCT05182931	(BRAF:V600E OR NRAS:oncogenic_mutation)
NCT05152147	(ERBB2:amplification OR ERBB2:overexpression)
NCT05364073	catype:Non-small cell lung cancer
NCT05311176	(catype:Gastroesophageal junction adenocarcinoma OR Gastroesophageal adenocarcinoma OR catype:Gastric Cancer)
NCT05440786	catype:Ewings sarcoma
